Prelude Therapeutics
PRLD on XNAS, Prelude Therapeutics Incorporated
Measures activity, not value. Not investment advice.
Latest month (Mar 2025)
1
0.7× the 3-year median
Last 12 months
3
+200% vs the 12 months before
Sharp changes
0
H-1B/E-3 applications change
Median offered wage (Mar 2025) The median yearly wage offered in the visa applications certified that month.
$73K
H-1B/E-3 applications that month
Not enough history to drawWorksite states (Mar 2025) How many US states the jobs in the company's visa applications are located in.
1
states named in that month's visa applications
What usually follows Visa hiring growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
DOL visa applications by month; published quarterly. Dashed: 3-year median.
See the numbers
| Month of Mar 2025: 1 |
| Month of Aug 2024: 2 |
| Month of May 2023: 1 |
| Month of May 2022: 1 |
| Month of Apr 2022: 2 |
| Month of Apr 2021: 2 |
| Month of Feb 2020: 1 |
What the numbers say
- H-1B/E-3 applications certified: 1 in March 2025, 0.7× the 3-year median; the most since Aug 2024.
Every measure from this source
5 years, by the period each figure describes
Sharp changes
0 in all loaded history, strongest first
No sharp change of this kind in all loaded history.
The records
One row per company, data through 28 Sep 2026
| Company | Sector | Last 12 months | vs year before |
|---|---|---|---|
| Prelude Therapeutics | Health Care | 0 | -100% |